Global Hepatitis B Vaccines Market to Reach $3.4 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Dec 2, 2022--

The "Hepatitis B Vaccines: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Hepatitis B Vaccines Market to Reach $3.4 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Hepatitis B Vaccines estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027. Combination Vaccines, one of the segments analyzed in the report, is projected to record 4.4% CAGR and reach US$2.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mono Vaccines segment is readjusted to a revised 3.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $715.6 Million, While China is Forecast to Grow at 6.5% CAGR

The Hepatitis B Vaccines market in the U.S. is estimated at US$715.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$668.6 Million by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Select Competitors (Total 14 Featured) -

• Beijing Minhai Biotechnology Co., Ltd.
• Bharat Biotech International Ltd.
• Binnopharm Group LLC
• Biokangtai
• CSL Ltd.
• Dynavax Technologies Corporation
• Emergent BioSolutions, Inc.
• GlaxoSmithKline PLC
• Hualan Biological Engineering Co., Ltd.
• Merck & Co., Inc.

What's New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• Hepatitis B Vaccines - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Companies Mentioned

• Beijing Minhai Biotechnology Co., Ltd.
• Bharat Biotech International Ltd.
• Binnopharm Group LLC
• Biokangtai
• CSL Ltd.
• Dynavax Technologies Corporation
• Emergent BioSolutions, Inc.
• GlaxoSmithKline PLC
• Hualan Biological Engineering Co., Ltd.
• Merck & Co., Inc.

For more information about this report visit https://www.researchandmarkets.com/r/oixc6p

View source version on businesswire.com:https://www.businesswire.com/news/home/20221202005136/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.